Adding ultralow-dose naltrexone to oxycodone enhances and prolongs analgesia: a randomized, controlled trial of Oxytrex.
about
Oral or transdermal opioids for osteoarthritis of the knee or hipLong-term opioid treatment of chronic nonmalignant pain: unproven efficacy and neglected safety?A comparison between enriched and nonenriched enrollment randomized withdrawal trials of opioids for chronic noncancer painOxytrex: an oxycodone and ultra-low-dose naltrexone formulationOxycodone plus ultra-low-dose naltrexone attenuates neuropathic pain and associated mu-opioid receptor-Gs coupling.Gabapentin improves cold-pressor pain responses in methadone-maintained patients.Human abuse liability assessment of oxycodone combined with ultra-low-dose naltrexone.Meta-analysis of dropout rates in randomized controlled clinical trials: opioid analgesia for osteoarthritis pain.Opioid formulations with sequestered naltrexone: a perspective review.Advances in opioid antagonist treatment for opioid addiction.Effects of combined opioids on pain and mood in mammals.Strategies to reduce the tampering and subsequent abuse of long-acting opioids: potential risks and benefits of formulations with physical or pharmacologic deterrents to tampering.Highlights in opioid agonists and antagonists.Issues in long-term opioid therapy: unmet needs, risks, and solutions.Opioids in chronic non-cancer pain.Evidence from basic research for opioid combinations.A review of pharmacotherapy for chronic low back pain with considerations for sports medicine.Oxycodone combined with opioid receptor antagonists: efficacy and safety.Sequestered naltrexone in sustained release morphine or oxycodone - a way to inhibit illicit use?Comparable effects of exercise and analgesics for pain secondary to knee osteoarthritis: a meta-analysis of trials included in Cochrane systematic reviews.Antagonist-agonist combinations as therapies for heroin addiction: back to the future?Ultra-low dose naltrexone attenuates chronic morphine-induced gliosis in rats.A randomized clinical trial of the effects of ultra-low-dose naloxone infusion on postoperative opioid requirements and recovery.Ultra-Low Doses of Naltrexone Enhance the Antiallodynic Effect of Pregabalin or Gabapentin in Neuropathic Rats.Potentiation of buprenorphine antinociception with ultra-low dose naltrexone in healthy subjects.Enhanced Buprenorphine Analgesia with the Addition of Ultra-low-dose Naloxone in Healthy Subjects
P2860
Q24240601-6F3FAC1C-42F9-465D-AF08-869C87477836Q24598228-3CD25A8B-77E4-4235-96A0-B2CB20E811D6Q26991960-671D8981-1EF2-461F-A1BF-315D32455CC8Q28239922-A1E06AFE-95A7-4007-86FF-3507AE68B242Q33793250-A109ACBB-AB1D-4E62-8D79-3120DC1E1141Q33872764-AEC3B3A6-D87F-4952-83C4-2A9313D206E7Q33884718-485E03AC-04B7-46AF-8AE7-DEBAB970C999Q33912585-43FEC4E7-9156-4752-A1D2-33E0C7796DE1Q33949447-698EE15D-43BA-4E73-B1D5-C936D9B00D83Q34262649-6C89AD1C-6BBD-4B00-9DF8-704273B12660Q35884913-F22C0515-90B0-4776-BAFE-9FC718D46A38Q36399627-82CA04BB-B7FF-490C-9D64-C0BD1862B635Q36453307-C04802AB-E415-4B1C-AE82-D083BE380FE6Q37246241-F6E32653-EA45-48ED-8AE5-F0904EC906C2Q37831309-B6D2D0A9-55AF-44E1-87ED-74052E05368FQ37999097-34FF8D4D-D0C9-407F-B3AD-B3A172CB3496Q38073084-871853AE-35C8-403D-8C12-9188D1118178Q38093671-EDEF0356-8DB4-4502-A967-85440B39FB5EQ38160935-9BE46522-22BD-49F3-BA2F-4451E0954740Q38877801-BFE66492-3598-4314-B272-A0F4337B283DQ39902056-74FE7862-7886-45CA-86B8-E16DE531D902Q40277139-26CD5281-317C-4320-B698-0D9CEDF634B5Q44329973-5C1DDFF1-3AAA-4881-B6EF-45E3CD7B4212Q48134405-7637DFFE-2E30-42EB-BE88-2C690DDCC167Q49074804-638A298E-2C99-4420-8061-65C145EEBA78Q59287032-ECC2C4AF-CAAD-48F7-BD43-77003F35783A
P2860
Adding ultralow-dose naltrexone to oxycodone enhances and prolongs analgesia: a randomized, controlled trial of Oxytrex.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Adding ultralow-dose naltrexon ...... , controlled trial of Oxytrex.
@en
Adding ultralow-dose naltrexon ...... , controlled trial of Oxytrex.
@nl
type
label
Adding ultralow-dose naltrexon ...... , controlled trial of Oxytrex.
@en
Adding ultralow-dose naltrexon ...... , controlled trial of Oxytrex.
@nl
prefLabel
Adding ultralow-dose naltrexon ...... , controlled trial of Oxytrex.
@en
Adding ultralow-dose naltrexon ...... , controlled trial of Oxytrex.
@nl
P2093
P1433
P1476
Adding ultralow-dose naltrexon ...... , controlled trial of Oxytrex.
@en
P2093
K Peony Yu
Lindsay H Burns
Nadav Friedmann
Peter G Butera
Richard A Craven
Vishala L Chindalore
P304
P356
10.1016/J.JPAIN.2005.01.356
P577
2005-06-01T00:00:00Z